ClinicalTrials.gg

Carcinoma, Neuroendocrine clinical trials

The registry lists 172 studies for Carcinoma, Neuroendocrine across more than 10 countries. 66 are recruiting or about to start. 112 of them are mainly about Carcinoma, Neuroendocrine (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13. Counting its 4 narrower conditions too, such as Carcinoma, Merkel Cell: 498 studies, 135 open.

Get an email when these change. Save the Carcinoma, Neuroendocrine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
56
Recruiting
47
Active, not recruiting
19
Status unknown
18
Not yet recruiting
15
Terminated
8

Phase

Phase 2
110
Phase 1
44
Phase 3
8
Phase 4
1

Where

United States
73
China
39
Italy
18
France
17
Germany
10
Spain
10

What is being tested here

Drugs under test in Carcinoma, Neuroendocrine studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Immune checkpoint inhibitors 9 open · Tyrosine kinase inhibitors (TKIs) 4 open · Antimetabolites 1 open · HDAC inhibitors 1 open · Alkylating agents 6

Coming up

23studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 47 Carcinoma, Neuroendocrine studies recruiting now, 30 (64%) set no upper age limit and 10 (21%) stop at 75 or younger. 2 (4%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 47
AgeWomenMen
101 (2%)1 (2%)
1845 (96%)45 (96%)
3047 (100%)47 (100%)
4046 (98%)46 (98%)
5046 (98%)46 (98%)
6546 (98%)46 (98%)
7544 (94%)44 (94%)
8535 (74%)35 (74%)

Across all 172 studies, recruiting or not: 13% stop at 75 or younger and 1% at 65; 8% take children; 1% are for women only and 0% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Carcinoma, Neuroendocrine studies take

Of 43 phase 2 interventional studies under Carcinoma, Neuroendocrine, half reached primary completion within 69 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 269 mo50–91 · 43 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 172. Browse all 172 → or search them.